Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Pancreatic Neoplasms 1 Medulloblastoma 1 Liver Cirrhosis 1 Leiomyosarcoma 1 Drug-drug Interaction,SHR3680 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Malignancies 1 Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 14 Temozolomide 11 Vincristine 9 Magnetic Resonance Spectroscopy 9 Cisplatin 9 Etoposide 8 Specimen Handling 7 Radiotherapy 7 X-Rays 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 5 Lomustine 5 Carboplatin 5 Methotrexate 4 Irinotecan 4 Biopsy 4 etoposide phosphate 3 Thiotepa 3 Radiation 3 Platinum 3 Nivolumab 3 Filgrastim 3 Celecoxib 3 Bevacizumab 3 Automobiles 3 1,2-diaminocyclohexaneplatinum II citrate 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Digoxin × 1 year × Clear all

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡